The U.S. Patent Office allowed patent claims last month on whatcould be the ultimate niche imaging device: hand-held MRI. Magnevuof Carlsbad, CA, will first approach the veterinary market withthe technology, because Food and Drug Administration
The U.S. Patent Office allowed patent claims last month on whatcould be the ultimate niche imaging device: hand-held MRI. Magnevuof Carlsbad, CA, will first approach the veterinary market withthe technology, because Food and Drug Administration evaluationfor human use could take a while, according to president Dan Clark.
Clark, a former Technicare vice president and president ofthe now-defunct MPDI image processing firm, teamed up with FreemanRose, former chairman of Medstone, in developing the hand-heldMRI concept. Peter Taylor, another ex-Technicare executive, wasalso involved in the device's conception, Clark said.
Initially, the concept of using a small magnet and coil ina non-homogeneous field placed close to tissue was developed asa potential heat-monitoring technique for prostate disease therapy.It soon became clear, however, that the 7 x 7-inch MRI probe couldprovide clinically useful--albeit small field-of-view--images.
"The system has peripherals, including a keyboard andcomputer, but the technology really resides in the little probe.Inside it are the magnet, coils and antenna. All are placed closeup to the tissue that you are viewing," Clark told SCAN.The probe is attached by a wire to its computer.
The MR device will provide real-time images, equivalent inquality to those produced by standard MRI scanners, potentiallyin a private-office setting, Clark said. Magnevu intends to eventuallymarket the device using a fee-per-service program.
Two privately financed firms are behind the niche MRI effort.Magnevu was formed three years ago for the purpose of commercializingthe technology, he said. Panacea Medical Laboratory, led by Roseas president, controls the R&D side.
The two executives and a third investor own both companies.No venture capital firms are involved. Additional funds have beenraised through limited partnerships and debt, Clark said.
Could AI-Powered Abbreviated MRI Reinvent Detection for Structural Abnormalities of the Knee?
April 24th 2025Employing deep learning image reconstruction, parallel imaging and multi-slice acceleration in a sub-five-minute 3T knee MRI, researchers noted 100 percent sensitivity and 99 percent specificity for anterior cruciate ligament (ACL) tears.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.